System Transmission

Top Signal

100#1 JOB

Activity

2191Ripe

+951 today

System

Live1m

Terminal Asset View

stockNASDAQ

DVAX

$15.50+0.00%

Dynavax Technologies Corp

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

44Neutral

Live Analysis Active

Company Mission

Dynavax Technologies Corp creates vaccines and treatments for diseases such as hepatitis B and COVID-19. Doctors and hospitals use these products to protect patients from infections. The company makes money by selling these vaccines and forming partnerships with governments and other healthcare organizations.

DVA

Industry Context

This company operates in the biotechnology sector, focusing on developing vaccines and therapies for infectious diseases. It competes with larger pharmaceutical firms by targeting specific markets like hepatitis B and COVID-19. The industry is driven by innovation and regulatory approvals, with companies often partnering with governments for distribution.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

81Matrix

Market Momentum

84.8— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

2.5x— Normal Volume

Today's Change

0.00%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-0

Price is extended significantly above 52-week highs.

RSI Saturation-0

Momentum is saturated (Overbought). High risk of mean reversion.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing DVAX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:35 AM UTC

Develops vaccines and treatments for infectious diseases, earning revenue from product sales and partnerships with pharmaceutical companies.

Technical Pattern is forming near $15, suggesting Bullish momentum as it aligns with recent positive clinical trial results. Watch for price breaking above this level.

Volume spiked 2x at $14, indicating Buyer interest because of increased demand for its vaccines. Monitor if volume stays above average.

Industry Trend is driving strength, with price holding above $13, signaling growth in the biotech sector. Watch for industry expansion and regulatory approvals.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...